Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
insulin resistance7794 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A50637 | 35318963 | J Endocrinol | AKR1D1 knockout mice develop a sex-dependent metabolic phenotype. | 2022 | Details |
A50638 | 35318738 | Phytother Res | Effect of rosemary leaf powder with weight loss diet on lipid profile, glycemic status, and liver enzymes in patients with nonalcoholic fatty liver disease: A randomized, double-blind clinical trial. | 2022 | Details |
A50651 | 35314476 | BMJ Open | Role of age, gender and ethnicity in the association between visceral adiposity index and non-alcoholic fatty liver disease among US adults (NHANES 2003-2018): cross-sectional study. | 2022 | Details |
A50657 | 35311933 | Am J Clin Pathol | Clinical, Laboratory, and Histologic Correlates of Serum Antinuclear Antibody in Hispanic Pediatric Patients With Nonalcoholic Fatty Liver Disease. | 2022 | Details |
A50668 | 35308224 | Front Pharmacol | Pharmacological Effects and Molecular Protective Mechanisms of Astragalus Polysaccharides on Nonalcoholic Fatty Liver Disease. | 2022 | Details |
A50672 | 35307033 | BMC Med | Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study). | 2022 | Details |
A50684 | 35303270 | J Endocrinol Invest | Non-alcoholic fatty liver disease through the female lifespan: the role of sex hormones. | 2022 | Details |
A50689 | 35301333 | Nat Commun | Autophagy impairment in liver CD11c+ cells promotes non-alcoholic fatty liver disease through production of IL-23. | 2022 | Details |
A50690 | 35300452 | Indian J Endocrinol Metab | One-Hour Postload Plasma Glucose in Obese Indian Adults with Nonalcoholic Fatty Liver Disease: An Observational Study from North India. | 2022 | Details |
A50710 | 35291351 | Med (N Y) | Metreleptin therapy for nonalcoholic steatohepatitis: Open-label therapy interventions in two different clinical settings. | 2021 | Details |
A50713 | 35290413 | PLoS One | Abelmoschus esculentus subfractions ameliorate hepatic lipogenesis and lipid uptake via regulating dipeptidyl peptidase-4-With improving insulin resistance. | 2022 | Details |
A50736 | 35283265 | Diabetes Res Clin Pract | Prevalence of non-alcoholic fatty liver disease (NAFLD) and its association with surrogate markers of insulin resistance in patients with type 1 diabetes. | 2022 | Details |
A50741 | 35282455 | Front Endocrinol (Lausanne) | Efficacy and Safety of Empagliflozin on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. | 2022 | Details |
A50743 | 35280896 | Front Med (Lausanne) | Increased Oxygen Desaturation Time During Sleep Is a Risk Factor for NASH in Patients With Obstructive Sleep Apnea: A Prospective Cohort Study. | 2022 | Details |
A50769 | 35273160 | Nat Commun | Deep proteomic profiling unveils arylsulfatase A as a non-alcoholic steatohepatitis inducible hepatokine and regulator of glycemic control. | 2022 | Details |
A50770 | 35272243 | Phytomedicine | Therapeutic effect and mechanism of polysaccharides from Anoectochilus Roxburghii (Wall.) Lindl. in diet-induced obesity. | 2022 | Details |
A50776 | 35269912 | Int J Mol Sci | Natural Compounds for Counteracting Nonalcoholic Fatty Liver Disease (NAFLD): Advantages and Limitations of the Suggested Candidates. | 2022 | Details |
A50778 | 35269812 | Int J Mol Sci | Nuclear Receptors Linking Metabolism, Inflammation, and Fibrosis in Nonalcoholic Fatty Liver Disease. | 2022 | Details |
A50783 | 35268466 | J Clin Med | The Coexistence of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus. | 2022 | Details |
A50788 | 35266164 | Aliment Pharmacol Ther | Review article: role of glucagon-like peptide-1 receptor agonists in non-alcoholic steatohepatitis, obesity and diabetes-what hepatologists need to know. | 2022 | Details |
A50791 | 35265044 | Front Endocrinol (Lausanne) | Comprehensive Transcriptome Profiling of NAFLD- and NASH-Induced Skeletal Muscle Dysfunction. | 2022 | Details |
A50792 | 35264693 | Sci Rep | Clitorin ameliorates western diet-induced hepatic steatosis by regulating lipogenesis and fatty acid oxidation in vivo and in vitro. | 2022 | Details |
A50807 | 35234696 | Chin Med J (Engl) | Therapeutic developments in metabolic dysfunction-associated fatty liver disease. | 2022 | Details |
A50875 | 34675888 | Front Endocrinol (Lausanne) | Cardiovascular Endocrinology: Evolving Concepts and Updated Epidemiology of Relevant Diseases. | 2021 | Details |
A50892 | 34224877 | Clin Gastroenterol Hepatol | Liver Fibrosis in Asians With Metabolic Dysfunction-Associated Fatty Liver Disease. | 2021 | Details |
A50975 | 29298875 | Gut | Take me to the liver: adipose tissue macrophages coordinate hepatic neutrophil recruitment. | 2018 | Details |
A50991 | 27817220 | Expert Rev Cardiovasc Ther | Ectopic fat: a target for cardiometabolic risk management. | 2016 | Details |
A51020 | 24988092 | Minerva Med | Vitamin D and NAFLD: the need for interventional trials. | 2014 | Details |
A51059 | 19015652 | Nat Clin Pract Gastroenterol Hepatol | What advice should be given to patients with NAFLD about the consumption of alcohol? | 2008 | Details |
A51060 | 18980229 | Hepatology | Risk of severe liver disease in NAFLD with normal ALT levels: a pediatric report. | 2008 | Details |
A51061 | 17911352 | Gut | Benefits of lifestyle modification in NAFLD. | 2007 | Details |
A51063 | 17458261 | Nihon Rinsho | [Metabolic syndrome and NAFLD/NASH]. | 2006 | Details |
A51069 | 16697746 | Gastroenterology | NAFLD, obesity, and bariatric surgery. | 2006 | Details |
A51080 | 15685567 | Gastroenterology | Adiponectin--tipping the scales from NAFLD to NASH? | 2005 | Details |
A51100 | 35766964 | J Med Food | Persimmon Water Extract Suppresses Hepatic Lipotoxicity by Regulating Lipid Metabolites. | 2022 | Details |
A51105 | 35745205 | Nutrients | Metabolic Impact of MKP-2 Upregulation in Obesity Promotes Insulin Resistance and Fatty Liver Disease. | 2022 | Details |
A51109 | 35724630 | Obes Facts | The visceral fat area to hip circumstance ratio (VHR) as a predictor for insulin resistance in a Chinese population with type 2 diabetes. | 2022 | Details |
A51110 | 35723657 | Child Obes | Probiotic Use in Children and Adolescents with Overweight or Obesity: A Scoping Review. | 2022 | Details |
A51115 | 35678694 | Curr Issues Mol Biol | Lycopus lucidus Turcz Water Extract Ameliorates the Metabolic Disorder by Up-Regulated Major Urinary Protein Expression in High-Fat Diet-Induced Obesity. | 2022 | Details |
A51121 | 35658903 | Mol Neurodegener | TREM2 in the pathogenesis of AD: a lipid metabolism regulator and potential metabolic therapeutic target. | 2022 | Details |
A51125 | 35617705 | J Med Food | Partial Replacement of High-Fat Diet with Beef Tallow Attenuates Dyslipidemia and Endoplasmic Reticulum Stress in db/db Mice. | 2022 | Details |
A51129 | 35600376 | Front Oncol | The Importance of Metabolic Syndrome Status for the Risk of Non-Viral Hepatocellular Carcinoma: A Nationwide Population-Based Study. | 2022 | Details |
A51140 | 35512972 | Fertil Steril | Heart health in polycystic ovary syndrome: time to act on the data. | 2022 | Details |
A51153 | 35458210 | Nutrients | The Dose-Response Effects of Consuming High Fructose Corn Syrup-Sweetened Beverages on Hepatic Lipid Content and Insulin Sensitivity in Young Adults. | 2022 | Details |
A51162 | 35417107 | J Pediatr Endocrinol Metab | Successful treatment of severe hypertriglyceridemia with icosapent ethyl in a case of congenital generalized lipodystrophy type 4. | 2022 | Details |
A51182 | 35323680 | Metabolites | Plasma Tsukushi Concentration Is Associated with High Levels of Insulin and FGF21 and Low Level of Total Cholesterol in a General Population without Medication. | 2022 | Details |
A51186 | 35296424 | Biochim Biophys Acta Mol Cell Biol Lipids | Mechanisms of intestinal triacylglycerol synthesis. | 2022 | Details |
A51227 | 10569299 | Am J Med | Association of nonalcoholic fatty liver disease with insulin resistance. | 1999 | Details |
A51312 | 35700043 | J Clin Invest | Myeloid FoxO1 depletion attenuates hepatic inflammation and prevents nonalcoholic steatohepatitis. | 2022 | Details |
A51321 | 35625751 | Biomedicines | Influence of Type 2 Diabetes in the Association of PNPLA3 rs738409 and TM6SF2 rs58542926 Polymorphisms in NASH Advanced Liver Fibrosis. | 2022 | Details |
A51330 | 35559132 | ACS Omega | Lipidomics Revealed Alteration of the Sphingolipid Metabolism in the Liver of Nonalcoholic Steatohepatitis Mice Treated with Scoparone. | 2022 | Details |
A51357 | 35332108 | Aging (Albany NY) | Mitophagy and mitochondrial dynamics in type 2 diabetes mellitus treatment. | 2022 | Details |
A51395 | 35830259 | FASEB J | Intervention with isoleucine or valine corrects hyperinsulinemia and reduces intrahepatic diacylglycerols, liver steatosis, and inflammation in Ldlr-/-.Leiden mice with manifest obesity-associated NASH. | 2022 | Details |
A51413 | 35704699 | Am J Physiol Cell Physiol | The microRNA-29 family - role in metabolism and metabolic disease. | 2022 | Details |
A51425 | 35592498 | Mol Ther Nucleic Acids | Subcutaneous delivery of FGF21 mRNA therapy reverses obesity, insulin resistance, and hepatic steatosis in diet-induced obese mice. | 2022 | Details |
A51426 | 35560370 | Hepatology | Lipocalin-2 Activates Hepatic stellate cells and Promotes Non-alcoholic Steatohepatitis in High-Fat Diet-Fed ob/ob mice. | 2022 | Details |
A51453 | 35285180 | FEBS J | HPS protects the liver against steatosis, cell death, inflammation, and fibrosis in mice with steatohepatitis. | 2022 | Details |
A51497 | 35815420 | Hepatol Res | MAFLD Directly Related to Liver Fibrosis Independent of Insulin Resistance, Hyperlipidemia, and Alcohol Intake in Morbidly Obese Patients. | 2022 | Details |
A51500 | 35794109 | Signal Transduct Target Ther | Trends in insulin resistance: insights into mechanisms and therapeutic strategy. | 2022 | Details |
A51505 | 35764560 | Zhonghua Nei Ke Za Zhi | [Comparison of criteria for metabolically healthy overweight/obesity in Shanghai Changfeng study]. | 2022 | Details |
A51506 | 35752830 | Lipids Health Dis | Comparison of the diagnostic value between triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio in metabolic-associated fatty liver disease patients: a retrospective cross-sectional study. | 2022 | Details |
A51507 | 35743314 | Int J Mol Sci | Adaptation of Oxidative Phosphorylation Machinery Compensates for Hepatic Lipotoxicity in Early Stages of MAFLD. | 2022 | Details |
A51508 | 35741222 | Diagnostics (Basel) | Urine Proteome in Distinguishing Hepatic Steatosis in Patients with Metabolic-Associated Fatty Liver Disease. | 2022 | Details |
A51518 | 35691476 | Diabetes Res Clin Pract | Fatty liver indices and their association with glucose metabolism in pregnancy - An observational cohort study. | 2022 | Details |
A51521 | 35655263 | Cardiovasc Diabetol | Impact of metabolic syndrome and metabolic dysfunction-associated fatty liver disease on cardiovascular risk by the presence or absence of type 2 diabetes and according to sex. | 2022 | Details |
A51522 | 35631255 | Nutrients | Vitamin D Status Presents Different Relationships with Severity in Metabolic-Associated Fatty Liver Disease Patients with or without Hepatitis B Infection. | 2022 | Details |
A51530 | 35532410 | J Clin Endocrinol Metab | Serum Thrombospondin-2 Levels Are Closely Associated With the Severity of Metabolic Syndrome and Metabolic Associated Fatty Liver Disease. | 2022 | Details |
A51536 | 35491295 | Trends Endocrinol Metab | SGLT-2 inhibitors and GLP-1 receptor agonists in metabolic dysfunction-associated fatty liver disease. | 2022 | Details |
A51540 | 35457118 | Int J Mol Sci | Emerging Evidence of Pathological Roles of Very-Low-Density Lipoprotein (VLDL). | 2022 | Details |
A51544 | 35394122 | Pediatr Obes | Development of a prediction protocol for the screening of metabolic associated fatty liver disease in children with overweight or obesity. | 2022 | Details |
A51572 | 35008356 | Cancers (Basel) | A Shortcut from Metabolic-Associated Fatty Liver Disease (MAFLD) to Hepatocellular Carcinoma (HCC): c-MYC a Promising Target for Preventative Strategies and Individualized Therapy. | 2021 | Details |
A51580 | 34889064 | J Diabetes Investig | Circulating level of fatty acid-binding protein 4 is an independent predictor of metabolic dysfunction-associated fatty liver disease in middle-aged and elderly individuals. | 2022 | Details |
A51585 | 34817168 | J Agric Food Chem | Estrogen Receptor α Regulates Metabolic-Associated Fatty Liver Disease by Targeting NLRP3-GSDMD Axis-Mediated Hepatocyte Pyroptosis. | 2021 | Details |
A51590 | 34738404 | Zhongguo Zhong Yao Za Zhi | [Mechanism of Gynostemma pentaphyllum in treatment of metabolism associated fatty liver disease based on network pharmacology and molecular docking]. | 2021 | Details |
A51594 | 34695608 | Mol Metab | Exercise prevents fatty liver by modifying the compensatory response of mitochondrial metabolism to excess substrate availability. | 2021 | Details |
A51611 | 35670755 | FASEB J | Normalization of maternal adiponectin in obese pregnant mice prevents programming of impaired glucose metabolism in adult offspring. | 2022 | Details |
A51617 | 35618993 | J Gastrointest Surg | Sleeve Gastrectomy Improves High-Fat Diet-Associated Hepatic Steatosis Independent of the Glucagon-like-Petpide-1 Receptor in Rats. | 2022 | Details |
A51619 | 35574038 | Front Endocrinol (Lausanne) | Role of Innate lymphoid Cells in Obesity and Insulin Resistance. | 2022 | Details |
A51627 | 35493783 | Anim Reprod | Rodent models in placental research. Implications for fetal origins of adult disease. | 2022 | Details |
A51631 | 35483188 | Biomed Pharmacother | Dietary administration of D-chiro-inositol attenuates sex-specific metabolic imbalances in the 5xFAD mouse model of Alzheimer's disease. | 2022 | Details |
A51638 | 35421452 | Life Sci | Characteristics and molecular mechanisms through which SGLT2 inhibitors improve metabolic diseases: A mechanism review. | 2022 | Details |
A51642 | 35325655 | Biochem Biophys Res Commun | 3-Hydroxyacyl-CoA dehydratase 2 deficiency confers resistance to diet-induced obesity and glucose intolerance. | 2022 | Details |
A51651 | 35268696 | Molecules | A Comprehensive Review on Therapeutic Perspectives of Phytosterols in Insulin Resistance: A Mechanistic Approach. | 2022 | Details |
A51656 | 35212667 | AIDS | Higher epicardial fat in older adults living with HIV with viral suppression and relationship with liver steatosis, coronary calcium and cardiometabolic risks. | 2022 | Details |
A51661 | 35173282 | Int J Obes (Lond) | Association of plasma kynurenine pathway metabolite concentrations with metabolic health risk in prepubertal Asian children. | 2022 | Details |
A51669 | 35070060 | World J Diabetes | Gut microbiota-derived metabolites are novel targets for improving insulin resistance. | 2022 | Details |
A51674 | 35040267 | Physiol Rep | Macrophage activation marker sCD163 is associated with liver injury and hepatic insulin resistance in obese patients before and after Roux-en-Y gastric bypass. | 2022 | Details |
A51681 | 34959746 | Nutrients | Blueberry Counteracts Prediabetes in a Hypercaloric Diet-Induced Rat Model and Rescues Hepatic Mitochondrial Bioenergetics. | 2021 | Details |
A51694 | 34847289 | FEBS J | Pathophysiology of type 2 diabetes and the impact of altered metabolic interorgan crosstalk. | 2021 | Details |
A51705 | 34774157 | Lancet Gastroenterol Hepatol | Metabolic dysfunction-associated fatty liver disease and insulin resistance in type 1 diabetes. | 2021 | Details |
A51708 | 34722722 | Visc Med | Obesity and Gallstones. | 2021 | Details |
A51710 | 34722187 | J Clin Transl Hepatol | Alcohol and Metabolic-associated Fatty Liver Disease. | 2021 | Details |
A51721 | 34603196 | Front Endocrinol (Lausanne) | Serum Afamin a Novel Marker of Increased Hepatic Lipid Content. | 2021 | Details |
A51727 | 34563954 | Biomed Pharmacother | Transcriptome analysis to reveal the mechanism of the effect of Echinops latifolius polysaccharide B on palmitate-induced insulin-resistant. | 2021 | Details |
A51733 | 34502170 | Int J Mol Sci | Pleiotrophin Deficiency Induces Browning of Periovarian Adipose Tissue and Protects against High-Fat Diet-Induced Hepatic Steatosis. | 2021 | Details |
A51735 | 34471717 | Heliyon | Adiponectin gene polymorphisms associated with diabetes mellitus: A descriptive review. | 2021 | Details |
A51762 | 34302121 | Int J Obes (Lond) | Non-hematopoietic IL-4Rα expression contributes to fructose-driven obesity and metabolic sequelae. | 2021 | Details |
A51765 | 34279029 | J Clin Endocrinol Metab | Circulating Bile Acid Profiles: A Need for Further Examination. | 2021 | Details |
A51769 | 34264866 | JCI Insight | Prolyl-4-hydroxylase 3 maintains β cell glucose metabolism during fatty acid excess in mice. | 2021 | Details |
A51771 | 34236076 | Clin Sci (Lond) | Glycoursodeoxycholic acid ameliorates diet-induced metabolic disorders with inhibiting endoplasmic reticulum stress. | 2021 | Details |